Literature DB >> 7476035

Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain.

O Zachrisson1, A A Mathé, C Stenfors, N Lindefors.   

Abstract

The aim of this study was to determine the effect of repeated electroconvulsive stimulation (ECS) on the expression of neuropeptide Y (NPY) and somatostatin (SS) mRNA in the rat brain. For that purpose, quantitative in situ hybridization histochemistry and RNA blot analysis were used. In the hippocampal formation the prevalence of NPY mRNA positive neurons increased in the hilus of the dentate gyrus and the CA3 while a decrease was seen in layers II-III of the entorhinal cortex. In contrast, SS mRNA was increased in the granule cells of the dentate gyrus and in most neurons of the outer parts of the layer III in the entorhinal cortex with cell bodies of perforant pathway projections to the hippocampal CA1 region. Both NPY and SS mRNA expressing neurons were increased in numerical density in the prefrontal cortex with similar amounts of mRNA in individual NPY positive neurons after the stimulations while SS mRNA levels decreased in hybridization positive neurons. In the striatum the only observed significant effect was an increased prevalence of NPY mRNA positive neurons in the caudal nucleus accumbens. Our results provide an outline of a complex functional anatomy of ECS in the rat brain. This type of investigations contributes to map the neuronal systems involved in the action of ECT used in the treatment of affective and schizophrenic disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7476035     DOI: 10.1016/0169-328x(95)00033-o

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  6 in total

1.  Effects of electroconvulsive stimuli and MK-801 on neuropeptide Y, neurokinin A, and calcitonin gene-related peptide in rat brain.

Authors:  A A Mathé; S Gruber; P A Jiménez; E Theodorsson; C Stenfors
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

2.  Neuropeptide expression in rats exposed to chronic mild stresses.

Authors:  Valeriy Sergeyev; Serguei Fetissov; Aleksander A Mathé; Patricia A Jimenez; Tamas Bartfai; Patrick Mortas; Laurent Gaudet; Jean-Luc Moreau; Tomas Hökfelt
Journal:  Psychopharmacology (Berl)       Date:  2004-10-30       Impact factor: 4.530

Review 3.  Neuropeptides in depression: role of VGF.

Authors:  Smita Thakker-Varia; Janet Alder
Journal:  Behav Brain Res       Date:  2008-10-15       Impact factor: 3.332

4.  Microarray Analysis of Human Blood During Electroconvulsive Therapy.

Authors:  Takao Kaneko; Tetsufumi Kanazawa; Masaki Nishiguchi; Hiroki Kikuyama; Atsushi Tsutsumi; Hiroyuki Uenishi; Yasuo Kawabata; Seiya Kawashige; Yoshitaka Nishizawa; Souichiro Maruyama; Jun Koh; Hiroshi Yoneda
Journal:  J ECT       Date:  2015-12       Impact factor: 3.635

Review 5.  Neuropeptide Y in Alcohol Addiction and Affective Disorders.

Authors:  Annika Thorsell; Aleksander A Mathé
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-31       Impact factor: 5.555

6.  Long-term valproate treatment increases brain neuropeptide Y expression and decreases seizure expression in a genetic rat model of absence epilepsy.

Authors:  Johanna Elms; Kim L Powell; Leena van Raay; Stefanie Dedeurwaerdere; Terence J O'Brien; Margaret J Morris
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.